1. Kuiken T, Taubenberger J. Pathology of human influenza revisited. 2008. 26: p. D59-D66. [
DOI:10.1016/j.vaccine.2008.07.025] [
PMID] [
PMCID]
2. Karbalaie Niya MH, Yavarian J, Shafiei Jandaghi NZ, Shahmahmoodi SH, Mokhtari Azad T. Comparison of real-time RT-PCR assay with direct sequencing for detection of sensitivity or resistant to oseltamivir in influenza A/H3N2 viruses. Virol & Antiviral Res. 2014. 3(1): 122-8. [
DOI:10.4172/2324-8955.1000120]
3. Mauad T , Hajjar L, Callegari G, et al., Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med. 2010;181(1): 72-9. [
DOI:10.1164/rccm.200909-1420OC] [
PMID]
4. Baskin C, Bielefeldt-Ohmann H, Tumpey T,et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A. 2009. 106(9): 3455-60. [
DOI:10.1073/pnas.0813234106] [
PMID] [
PMCID]
5. Roh GS,Seo SW,Yeo SK,et al. Efficacy of a traditional Korean medicine, Chung-Sang-Bo-Ha-Tang, in a murine model of chronic asthma. Int Immunopharmacol.2005;5(2): 427-36. [
DOI:10.1016/j.intimp.2004.09.036] [
PMID]
6. Kim J, Shin D, Lee G, et al. Standardized herbal formula PM014 inhibits radiation-induced pulmonary inflammation in mice. Sci Report. 2017; 7(1): 1-11.
https://doi.org/10.1016/j.ijrobp.2017.06.2049 [
DOI:10.1038/srep45001]
7. Traves S, Culpitt S, Russell R, Barnes P, Donnelly L.Increased levels of the chemokines GROα and MCP-1 in sputum samples from patients with COPD. Thorax. 2002. 57(7): p. 590-595. [
DOI:10.1136/thorax.57.7.590] [
PMID] [
PMCID]
8. Kim K , Lee S , Lee H,et al. A standardized herbal extract PM014 ameliorates pulmonary fibrosis by suppressing the TGF-β1 pathway.Sci Rep. 2018; 8(1): 1-12. [
DOI:10.1038/s41598-018-35320-8] [
PMID] [
PMCID]
9. Spagnolo P , Maher T , Richeldi L,et al., Idiopathic pulmonary fibrosis: recent advances on pharmacological therapy. Pharmacol Ther.2015; 152: 18-27. [
DOI:10.1016/j.pharmthera.2015.04.005] [
PMID]